Speaker: Simona Colla, PhD, Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center
"Targeting Clonal Cytopenia of Undetermined Significance"
Escape from immune surveillance is a hallmark of cancer. Immune deregulation caused by intrinsic and extrinsic cellular factors, such as altered T cell functions, leads to immune exhaustion, loss of immune surveillance, and clonal proliferation of tumoral cells. In this talk, Dr. Colla will present unpublished work from her lab that dissects how aberrant natural killer cells and the T cell immune system contribute to the pathogenesis, maintenance, and progression of myelodysplastic syndrome.
Location: Herbert Irving Comprehensive Cancer Center, 1130 St. Nicholas Ave., New York, NY 10032
Room/Area: 1st floor auditorium
Hosted by Stavroula Kousteni, PhD, Professor, Department of Physiology & Cellular Biophysics, CUMC; Director, Columbia Evans MDS Center
This event is sponsored by the Herbert Irving Comprehensive Cancer Center's (HICCC) Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at Columbia University, established to foster an all-encompassing approach in studying MDS giving us molecular, cellular genetic and epigenetic insights to develop and test innovative therapies.
